190 related articles for article (PubMed ID: 37875785)
21. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
Amaral T; Leiter U; Garbe C
Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
[TBL] [Abstract][Full Text] [Related]
22. Recent Insights and Advances in the Management of Merkel Cell Carcinoma.
Banks PD; Sandhu S; Gyorki DE; Johnston ML; Rischin D
J Oncol Pract; 2016 Jul; 12(7):637-46. PubMed ID: 27407160
[TBL] [Abstract][Full Text] [Related]
23. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
Colunga A; Pulliam T; Nghiem P
Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
Topalian SL; Bhatia S; Amin A; Kudchadkar RR; Sharfman WH; Lebbé C; Delord JP; Dunn LA; Shinohara MM; Kulikauskas R; Chung CH; Martens UM; Ferris RL; Stein JE; Engle EL; Devriese LA; Lao CD; Gu J; Li B; Chen T; Barrows A; Horvath A; Taube JM; Nghiem P
J Clin Oncol; 2020 Aug; 38(22):2476-2487. PubMed ID: 32324435
[TBL] [Abstract][Full Text] [Related]
25. S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022.
Becker JC; Beer AJ; DeTemple VK; Eigentler T; Flaig M; Gambichler T; Grabbe S; Höller U; Klumpp B; Lang S; Pföhler C; Posch C; Prasad V; Schlattmann P; Schneider-Burrus S; Ter-Nedden J; Terheyden P; Thoms K; Vordermark D; Ugurel S
J Dtsch Dermatol Ges; 2023 Mar; 21(3):305-320. PubMed ID: 36929552
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma.
Spassova I; Ugurel S; Kubat L; Zimmer L; Terheyden P; Mohr A; Björn Andtback H; Villabona L; Leiter U; Eigentler T; Loquai C; Hassel JC; Gambichler T; Haferkamp S; Mohr P; Pfoehler C; Heinzerling L; Gutzmer R; Utikal JS; Horny K; Schildhaus HU; Habermann D; Hoffmann D; Schadendorf D; Becker JC
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35074902
[TBL] [Abstract][Full Text] [Related]
27. Merkel Cell Carcinoma.
Lewis DJ; Sobanko JF; Etzkorn JR; Shin TM; Giordano CN; McMurray SL; Walker JL; Zhang J; Miller CJ; Higgins HW
Dermatol Clin; 2023 Jan; 41(1):101-115. PubMed ID: 36410971
[TBL] [Abstract][Full Text] [Related]
28. An update on Merkel cell carcinoma.
Sergi MC; Lauricella E; Porta C; Tucci M; Cives M
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188880. PubMed ID: 36914034
[TBL] [Abstract][Full Text] [Related]
29. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Georges S; Shah P; Ellers-Lenz B; Bajars M; Güzel G; Nghiem PT
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414862
[TBL] [Abstract][Full Text] [Related]
30. Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacy.
Marchand A; Kervarrec T; Bhatia S; Samimi M
Expert Rev Anticancer Ther; 2020 Dec; 20(12):1093-1106. PubMed ID: 33044876
[TBL] [Abstract][Full Text] [Related]
31. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
32. Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma.
Glutsch V; Kneitz H; Gesierich A; Goebeler M; Haferkamp S; Becker JC; Ugurel S; Schilling B
Cancer Immunol Immunother; 2021 Jul; 70(7):2087-2093. PubMed ID: 33439294
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022.
Gauci ML; Aristei C; Becker JC; Blom A; Bataille V; Dreno B; Del Marmol V; Forsea AM; Fargnoli MC; Grob JJ; Gomes F; Hauschild A; Hoeller C; Harwood C; Kelleners-Smeets N; Kaufmann R; Lallas A; Malvehy J; Moreno-Ramirez D; Peris K; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; van Akkooi ACJ; Lorigan P; Garbe C; Lebbé C;
Eur J Cancer; 2022 Aug; 171():203-231. PubMed ID: 35732101
[TBL] [Abstract][Full Text] [Related]
34. New perspectives in Merkel cell carcinoma.
Del Marmol V; Lebbé C
Curr Opin Oncol; 2019 Mar; 31(2):72-83. PubMed ID: 30694842
[TBL] [Abstract][Full Text] [Related]
35. S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018.
Becker JC; Eigentler T; Frerich B; Gambichler T; Grabbe S; Höller U; Klumpp B; Loquai C; Krause-Bergmann A; Müller-Richter U; Pföhler C; Schneider-Burrus S; Stang A; Terheyden P; Ugurel S; Veith J; Mauch C
J Dtsch Dermatol Ges; 2019 May; 17(5):562-576. PubMed ID: 31056838
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
D'Angelo SP; Russell J; Lebbé C; Chmielowski B; Gambichler T; Grob JJ; Kiecker F; Rabinowits G; Terheyden P; Zwiener I; Bajars M; Hennessy M; Kaufman HL
JAMA Oncol; 2018 Sep; 4(9):e180077. PubMed ID: 29566106
[TBL] [Abstract][Full Text] [Related]
37. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
Nghiem P; Bhatia S; Lipson EJ; Sharfman WH; Kudchadkar RR; Brohl AS; Friedlander PA; Daud A; Kluger HM; Reddy SA; Boulmay BC; Riker A; Burgess MA; Hanks BA; Olencki T; Kendra K; Church C; Akaike T; Ramchurren N; Shinohara MM; Salim B; Taube JM; Jensen E; Kalabis M; Fling SP; Homet Moreno B; Sharon E; Cheever MA; Topalian SL
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33879601
[TBL] [Abstract][Full Text] [Related]
38. Merkel cell carcinoma of the eyelid: A review.
North VS; Habib LA; Yoon MK
Surv Ophthalmol; 2019; 64(5):659-667. PubMed ID: 30871952
[TBL] [Abstract][Full Text] [Related]
39. Merkel cell carcinoma.
Ramahi E; Choi J; Fuller CD; Eng TY
Am J Clin Oncol; 2013 Jun; 36(3):299-309. PubMed ID: 21422993
[TBL] [Abstract][Full Text] [Related]
40. Avelumab and other recent advances in Merkel cell carcinoma.
Bommareddy PK; Kaufman HL
Future Oncol; 2017 Dec; 13(30):2771-2783. PubMed ID: 28976209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
